Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Malcolm Spicer

Senior Editor, Consumer Health

Washington, DC
Malcolm Spicer is lead analyst for Pharma intelligence | informa's coverage of the consumer health care products industries. He provides comprehensive and insightful reporting on manufacturing, marketing, regulation, legislation, financial and research news about the nonprescription drug and nutritional product industries. He has worked in this post for 10 years and previously reported for other publications on regulation of the health care industry, on the telecommunications and internet technologies and on the US energy market.
Set Alert for Articles By Malcolm Spicer

Latest From Malcolm Spicer

No Masking 'Excessive' Microorganisms In Evanhealy Cosmetics From FDA

Listings for more thazn 27,000 Plant Devas' evanhealy products are included in the latest update to FDA's database of regulated-product recalls that haven started by marketers or manufacturers and assigned a classification of urgency level, posted March 21.
US States United States

Shorter Exclusivity In House OTC Monograph Bill Could Gain Industry Acceptance To Speed Passage

The length of exclusivity periods is the only major difference between pending US House and Senate bills, both largely based on a proposal developed by FDA and drug industry representatives. Committees in both chambers are expected to vote on moving the bipartisan proposals to floor votes within two months.

Consumer Legislation

Post-Market Changes Too Late To Avoid UK Nutrition Claims Enforcement

Investigating consumer complaints challenging claims in Twitter and Instagram content that Carb Blocker capsules could stop unused sugars from being stored as fat in the body, Advertising Standards Authority says Protein World breached UK regulations for health and nutrition claims based on the European Union Register of approved claims for foods.

United Kingdom Europe

FDA Plans For Soy Health Claims, Pyridoxamine's Use Questioned By CRN, NPA

FDA’s proposed rule to revoke soy protein heart health ignores research supporting the claims and cites evidence that isn't compelling, CRN an NPA say in comments to the agency. CRN also submits comments supporting an ingredient firm's petition asking FDA to remove any uncertainty about the of use of pyridoxamine as a dietary ingredient.

United States Dietary Supplements

Alka-Seltzer Plus Labeling Error Prompts Recall From Some US Stores

Recall is second in a year for products marketed under the iconic Alka-Seltzer brand. Alka-Seltzer Plus line comprises products indicated for cold alone or for cough/cold; cold and flu and symptoms including sinus pressure, and are available in regular and extra-strength and day and night formulations.
United States Consumer

Processing Removes 'Natural' Claim For UK Meal-Replacement Bar Ingredients

UK firm contends processing ingredients into edible form is common across food and nutritional products industries and many foods consumers use regularly contains ingredients that long have been processed for use. Advertising Standards Authority points out a UK Food Standards Agency guidance explained that the use of solvents or other chemicals in processing disqualifies most processed ingredients from labeling as natural.

United Kingdom United States
See All